U.S. Markets
Johnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosciences for up to USD 3.4bln, according to FT
ORIGINAL · NewsquawkJohnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosciences for up to USD 3.4bln, according to FT
StockNow breaking-news AI analysis
The FT reports that Johnson & Johnson is considering acquiring Ollin Biosciences for up to USD 3.4 billion.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
